Neuroinflammation plays a role in the progression of several neurodegenerative disorders. We used a lipopolysaccharide (LPS) model of neuroinflammation to characterize the gene expression changes underlying the inflammatory and behavioral effects of neuroinflammation. A single intracerebroventricular injection of LPS (5 mg) was administered into the lateral ventricle of mice and, 24 h later, we examined gene expression in the cerebral cortex and hippocampus using microarray technology. Gene Ontology (GO) terms for inflammation and the ribosome were significantly enriched by LPS, whereas GO terms associated with learning and memory had decreased expression. We detected 224 changed transcripts in the cerebral cortex and 170 in the hippocampus. Expression of Egr1 (also known as Zif268) and Arc, two genes associated with learning and memory, was significantly lower in the cortex, but not in the hippocampus, of LPS-treated animals. Overall, altered expression of these genes may underlie some of the inflammatory and behavioral effects of neuroinflammation.
Introduction
Inflammation plays an important role in the body's defense against infection, but overactivation of the inflammatory cascade can have detrimental effects. In the central nervous system, inflammation is thought to be associated with normal aging 1 and to contribute to the progression of a number of pathological conditions, including Alzheimer's disease, 2 Parkinson's disease 3 and amyotrophic lateral sclerosis.
Although LPS is not directly toxic to mature neurons, which do not express TLR4, 8 neurons can be indirectly damaged by LPS-activated microglia. A number of studies in vitro have shown that exposing primary neuron/glia-mixed cultures to LPS leads to neuronal death, whereas no significant cell loss is observed in neuron-enriched cultures. 9, 10 Acute administration of LPS directly to the brain recapitulates these results, and leads to neuron death in the hippocampus. 11 Moreover, behavioral studies have shown that object recognition 12 and spatial memory 13 are both impaired in animals treated with single doses of LPS. In line with these cognitive deficits, long-term potentiation (LTP) is largely blocked following acute LPS injections. 12, 14 In an effort to characterize the transcriptional changes that underlie these physiological and behavioral effects, we examined changes in gene expression in the mouse hippocampus and cerebral cortex 24 h after a single intracerebroventricular (i.c.v.) injection of LPS using microarray technology.
Results
We began our analysis by filtering the data to include only probes with a reliable signal. A total of 9557 annotated genes, RIKEN sequences and expressed sequence tags passed the filtration step. Next, the raw intensity values from this dataset were normalized with a Z-transformation. 15 The original data file and the filtered, normalized results are available online in the Gene Expression Omnibus (GEO Accession GSE12284). Using the calculated Z-scores, we conducted a principal component analysis to reduce the dimensionality of the data and to enable visualization of the relationships between gene expression profiles, as shown in Figure 1a . The first principal component (PC1) separated the samples by brain region, and the second (PC2) did so on the basis of treatment. The first and second principal components accounted for 53.2 and 16.1% of total variance, respectively, indicating that brain region and treatment are responsible for the majority of the differences in gene expressions between the samples. To quantify the expression changes for each probe, we compared the Z-scores between the vehicle and LPS treatment groups using the Z-ratio statistic. 15 Positive Z-ratios indicate increased expression relative to control, and negative Z-ratios indicate reduced expression. A plot comparing hippocampus and cortex Z-ratios revealed a significant correlation between the changes in each brain region (r 2 ¼ 0.42, Po0.0001; Figure 1b ). To provide a functional interpretation of these effects, we conducted a gene set analysis with the parametric analysis of gene set enrichment (PAGE) algorithm using Gene Ontology (GO) terms and curated Molecular Signatures Database (MSigDB) gene sets. [16] [17] [18] GO terms are gene lists categorized by cellular localization, functional roles, and biological processes 16 that are not necessarily co-regulated. By contrast, curated MSigDB gene sets are lists of genes that have been shown to be commonly affected in human diseases or by various experimental conditions. 17 Our results revealed that a number of proinflammatory gene sets were enriched in both regions following LPS administration (Table 1) . Other gene sets with increased expression included GO Terms for ribosomal proteins and actin cytoskeletal reorganization, as well as an MSigDB set previously shown to be increased in the aged mouse neocortex. 19 A number of GO Terms associated with nervous system function showed significantly reduced expression in animals treated with LPS. In addition, we found that LPS caused the downregulation of a set of genes that has been shown to have decreased expression in the hippocampus of patients with Alzheimer's disease. 20 We next sought to identify individual genes that were affected by LPS. Using strict criteria, including a Z-ratio cutoff of ±1.5 and a P-value o0.05, we detected significant changes for 170 and 224 transcripts in the hippocampus and cerebral cortex, respectively (Tables 2 and 3 ). The complete lists of affected genes are available as supplementary data (Supplementary Tables S1 and S2 ). Sixty-four were significantly changed in both brain regions, and all of these were changed in the same direction on the microarray.
A number of these individually significant genes recapitulate the results of our gene set analysis; genes encoding ribosomal proteins, acute phase proteins and stress response proteins showed significantly increased expression, whereas those associated with nervous system function, and particularly neurotransmission, learning and memory, showed significantly reduced expression in both brain regions. Of particular interest are the genes for activity-regulated We used the parametric analysis of gene set enrichment (PAGE) algorithm to find Gene Ontology (GO) terms and curated Molecular Signatures Database (MSigDB) gene sets whose expression was altered during acute neuroinflammation. Significant changes were observed for a number of gene sets associated with inflammation and nervous system function in both brain regions. The PAGE Z-score reflects the size of a gene set and difference between the average Z-ratio within the set and the average Z-ratio for the entire array; Z-scores with a magnitude greater than ± 1.96 are considered statistically significant with Po0.05. 
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RH Bonow et al cytoskeletal-associated protein (Arc) and early growth response 1 (Egr1, also known as Zif 268), which are intimately involved in learning and memory. 21, 22 The microarray data indicated that Arc expression was significantly reduced in both the hippocampus (Z-ratio ¼ À1.84) and cerebral cortex (Z-ratio ¼ À5.92), whereas Egr1 was affected only in the cortex (Z-ratio ¼ À5.27).
We then validated our microarray results with real-time PCR using primers and probes for a subset of the genes that were found to be individually significant. These genes were chosen based on their biological relevance and for their wide range of positive and negative Z-ratios. The expression changes for 77% of the selected genes from the cortex were confirmed by PCR results, and 54% were reproducible in the hippocampus (Table 4) . A plot of fold change as assessed by PCR versus microarray Z-ratio revealed a strongly linear relationship for both brain regions (Figures 2a and b) . However, one gene, Cxcl12, was shown by PCR to be increased by 34% in the hippocampus despite having a negative Z-ratio (Z-ratio ¼ À3.54). PCR showed a significant reduction in Arc mRNA following LPS in the cortex, but there was no statistically significant difference in the hippocampus (Figures 3a and b) . Similarly, Egr1 expression was significantly reduced in the cortex, but not in the hippocampus (Figures 3c and d ).
Discussion
The goal of this study was to characterize the changes in gene expression that occur in the mouse hippocampus and cerebral cortex in response to direct activation of innate immunity by centrally injected LPS. Although previous studies have described the effects of peripheral LPS administration on the whole mouse brain transcriptome, 23, 24 and one has described the gene expression changes that occur in the hippocampus after a central injection of LPS, 25 ours is the first to compare the gene expression profiles of these two brain regions during acute neuroinflammation. Our results reveal that although the two brain regions have unique gene expression profiles at baseline, the expression changes induced by LPS are similar in both hippocampus and cerebral cortex. This finding suggests that, on the whole, both regions respond similarly to acute neuroinflammation.
A functional interpretation of these responses was provided by surveying the effects of LPS on predefined sets of genes from the GO project and MSigDB. 16, 17 Several GO terms associated with inflammation, including inflammatory response, chemokine activity, cytokine activity, neutrophil chemotaxis and leukocyte chemotaxis, were highly upregulated in both hippocampus and cortex following LPS treatment. In both regions, we also detected significant enrichment of a set of genes that was previously shown to have increased expression in the aged mouse neocortex, 19 further supporting the concept that brain inflammation increases during normal aging. 1 Overall, the results of the gene set analysis in the hippocampus and cortex were strikingly similar, and are indicative of a marked inflammatory response.
Expression of mRNA encoding ribosomal proteins was also increased in both regions at the level of gene sets and individual genes, which suggests that the brain is working to increase its capacity for protein synthesis. In support of this observation, a previous study in rats reported that chronic infusion of LPS caused ultrastructural changes in neurons consistent with impaired cytosolic protein synthesis. The authors also noted deep invaginations in nuclear membranes that were filled with polyribosomes, which they interpreted as an attempt by neurons to compensate for impaired cytosolic translation. 26 The increased transcription of ribosomal proteins that we observed would support this conclusion. However, because activated microglia are 26, 27 it is possible that the increase we found is at least in part due to transcriptional changes that occur in microglia as they become activated. Further work will be required to determine the individual contributions of neurons and glia to this effect.
The GO terms learning and/or memory, synaptic transmission and neuron migration were decreased in both hippocampus and cerebral cortex, which suggests that neural dysfunction occurs in both regions as a consequence of acute neuroinflammation. Indeed, LPS-induced neuroinflammation has been shown to adversely affect neurogenesis, neurite outgrowth and LTP. 12, [28] [29] [30] These are important processes in the adult nervous system, and their disruption likely contributes to the impaired cognitive performance of rodents treated with LPS.
The ephrin receptor B1 (EphB1) is involved in the differentiation and migration of neural precursors in the adult hippocampus and in the morphogenesis of neurites and dendritic spines. 31, 32 We observed significantly reduced expression of this transcript in both brain regions (cerebral cortex: Z-ratio ¼ À2.45, PCR fold change ¼ À1.31; hippocampus: Z-ratio ¼ À2.53, PCR fold change ¼ À1. 41) , and this may contribute to the impaired neurogenesis and to the reduced number of dendritic spines observed during neuroinflammation. 28, 30, 33 Despite the overall similarities in transcriptional changes in hippocampus and cerebral cortex, the plasticityassociated immediate-early genes, Arc and Egr1, were found to be decreased only in the cerebral cortex on PCR validation. Arc protein has been shown to regulate actin polymerization and AMPA receptor trafficking at synapses, and Egr1 is a transcription factor that regulates the expression of a number of plasticity-associated target genes, including Arc. 21, [34] [35] [36] [37] Both genes are rapidly transcribed postsynaptically following stimuli that produce behavioral learning or LTP, and transgenic animals lacking either gene exhibit impaired memory and weakened LTP. 21, 22, [38] [39] [40] Given the importance of Arc and Egr1 in memory, it is plausible that their reduced expression underlies the memory deficits observed in neuroinflammation. In support of this concept, an antisense-mediated knockdown of Arc protein translation has been shown to impair the maintenance of LTP, but not to affect its induction. 41 Hennigan et al. 12 obtained similar results using an acute peripheral injection of LPS to induce neuroinflammation; the authors observed a significant impairment in LTP maintenance, but no change in LTP induction. In both studies, the deficits in LTP were evident within 1 h of induction. Reduced Egr1 expression may also contribute to inflammation-induced memory impairment; both LPS-treated rats and Egr1 À/À mice perform similarly on tests of object recognition and fail to show preference for novel objects 24 h after training. 12, 38 These striking similarities suggest that impaired Arc and Egr1 expression may contribute to the memory problems that occur as a consequence of neuroinflammation. However, immediate-early genes such as Arc and Egr1 can serve as markers for neural activity, 21, 40, 42 so it is also plausible that the reduction we observed is a consequence of diminished neural activity in the cerebral cortex. Indeed, a study by Vereker et al., 14 using the same paradigm as Hennigan but with twice the dose of LPS, characterized significant deficits in both the induction and maintenance of LTP, which they attributed to lowered glutamate release. These results point to decreased excitatory neurotransmission, which would also produce the reductions in Arc and Egr1 transcription that we observed. Since these models of neuroinflammation used peripheral injections of LPS in rats and we used centrally injected LPS in mice, it is difficult to directly compare the dosing regimens; further studies will be required to determine if glutamate release is affected in our model as well. A possible effect of the anesthetic used before killing the animals should also be considered, as general anesthesia has been shown to interfere with the expression of neuronal immediate-early genes. [43] [44] [45] [46] Additional work should be conducted to address this possibility.
Rosi et al. 47 previously linked chronic inflammation to increased Arc expression in the dorsal rat hippocampus after chronic i.c.v. infusion of low doses of LPS. Though the combined in situ hybridization and cell counting technique used in their study is notably different from the microarray and real-time PCR approach that we employed, the contrast between their results and ours suggests that acute and chronic neuroinflammation may have divergent effects on Arc, and possibly Egr1, transcription. Expression of these two genes has been shown to be lowered in association with b-amyloid plaques in AD patients, animal models of AD and aged mice. 48, 49 Our results indicate that the inflammatory component of Alzheimer's and normal aging may be responsible for this effect. In line with this hypothesis, treatment with the nonsteroidal anti-inflammatory drug indomethacin restores memory performance and LTP in animal models of AD. 50 However, it is not known whether anti-inflammatory treatment also restores Arc and Egr1 expression to normal levels. Future studies should investigate this possibility.
The results of this study indicate that, on the whole, gene expression profiles of the hippocampus and cerebral cortex are similarly affected by acute neuroinflammation. However, despite the overall similarity between the two brain regions, we observed reduced transcription of plasticity-associated genes in the cerebral cortex, but not hippocampus. The gene expression changes that we have characterized contribute to the understanding of brain inflammation, and may aid in the development of new therapies for diseases with a neuroinflammatory component.
Materials and methods

Animals and tissue processing
All animal procedures were conducted under an NICHDapproved animal protocol in accordance with NIH guidelines for the care and use of laboratory animals. Mice (12-to 15-weeks old) bred on a C57BL/6 and SV129/Ola genetic background were anesthetized with intraperitoneal (i.p.) ketamine (100 mg kg À1 ) and xylazine (10 mg kg À1 ) and placed on a stereotactic table (Kopf Instruments, Tujunga, CA, USA). Using a 33-gauge needle (World Precision Instruments, Sarasota, FL, USA) attached to a microsyringe pump (Stoelting, Wood Dale, IL, USA), sterile phosphatebuffered saline (PBS) vehicle (5 ml) or LPS (E. coli serotype 127:B8; 5 mg in 5 ml sterile PBS) was injected into the lateral ventricle (À2.3 mm dorsal/ventral, À1.0 mm lateral and À0.5 mm anterior/posterior from bregma) at a rate of 1.0 ml min À1 , as previously described. 11, 33, 51 Twenty-four hours after surgery, animals were killed with an overdose of sodium pentobarbital (100 mg kg
À1
, i.p.) and immediately decapitated. Although other studies have shown a peak in inflammatory markers such as interleukin-1b or iNOS at 6 h after systemic LPS injection, 52 ,53 the dose of LPS used in our study, when injected intracerebroventricularly, produced a peak in most inflammatory markers examined at 24 h in a preliminary time course pilot study. This time point has been shown by us and others to produce significant levels of neuroinflammatory and oxidative stress markers when measured at 24 h after i.c.v. injection of LPS. 11, 51, 55, 56 The hippocampus and cerebral cortex from both hemispheres were rapidly dissected, flash frozen in 2-methylbutane at À60 1C, and stored at À80 1C. Total RNA was extracted from hippocampus and cortex samples using Qiagen RNeasy Lipid Tissue Mini and Midi kits, respectively (Qiagen, Valencia, CA, USA). RNA quality was assessed by measuring the A 260/280 ratio. RNA integrity was verified by visualization of the 28S and 18S ribosomal rRNA bands, with no presence of smear, using a denaturing agarose gel.
Microarray
Four samples from each brain region and treatment group were used. A 0.5 mg aliquot of total RNA from each sample was labeled using the Illumina TotalPrep RNA Amplification Kit (Ambion, Austin, TX, USA). RNA was first converted into single-stranded cDNA using reverse transcription with an oligo-dT primer containing the T7 RNA polymerase promoter, and then the single-stranded cDNA was copied to produce double-stranded cDNA molecules. The doublestranded cDNA was used in an overnight in vitro transcription reaction where single-stranded RNA (cRNA) was generated and labeled by incorporating biotin-16-UTP. A total of 0.75 mg of biotin-labeled cRNA was hybridized for 16 h to Illumina's Sentrix MouseRef-8 Expression BeadChips (Illumina, San Diego, CA, USA). Each BeadChip has 24 000 well-annotated RefSeq transcripts per sample with approximately 30-fold redundancy. The arrays were washed and blocked. Biotinylated cRNA was detected with streptavidinCy3 and quantitated using Illumina's BeadStation Â 500 Genetic Analysis Systems scanner. The image data was extracted using BeadStudio software (Illumina).
Data analysis
The expression data were filtered to include only probes with a consistent signal on each chip; the cut-off value was established at Po0.02. The resulting dataset was next analyzed with DIANE 6.0, a spreadsheet-based microarray analysis program. An overview of DIANE can be found online at http://www.grc.nia.nih.gov/branches/rrb/dna/ diane_software.pdf. Using DIANE, the background was subtracted from the raw signal intensity of each gene, and the results were normalized with a Z-score transformation.
15 Z-normalized data were then analyzed with principal component analysis. To determine the gene expression changes caused by LPS, Z-scores for the vehicle and LPS treatment groups were compared using the Z-ratio statistic:
Gene set analysis was performed using the PAGE algorithm 18 to detect GO terms 16 and curated MSigDB gene sets 17 affected by LPS. Only MSigDB gene sets with more than 30% representation in the filtered dataset were included in our analysis. Expression changes for individual genes were considered significant if they met four criteria: Z-ratio above 1.5 or below À1.5; false detection rate 57 of less than 0.30; a P-value statistic for Z-score replicability below 0.05; and mean background-corrected signal intensity greater than zero. As the Z-ratio statistic incorporates log-normalized Z-scores, the logarithm of the fold change as assessed by PCR must be used in calculating the linear regression. The strong correlation between PCR results and microarray data indicate that the expression changes observed using the microarray are real and reproducible with more sensitive methods.
Quantitative real-time polymerase chain reaction Microarray results were validated by quantitative real-time PCR, as previously described. 51, 58 In addition to the samples used for the microarray, we added 3 and 4 mice for the vehicle (total n ¼ 7) and LPS treatment group (total n ¼ 8), respectively. The following TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA, USA) were used: Adcy8 (Mm00507722_m1), Apod (Mm00431817_m1), Arc (Mm00479619_g1), Ccl12 (Mm01617100_m1), Cxcl12 (Mm00445552_m1), Egr1 (Mm00656724_m1), Ephb1 (Mm00557961_m1), Gabra1 (Mm00439040_m1), Gpx1 (Mm00656767_g1), Grm5 (Mm00690332_m1), Mtap1b (Mm00485261_m1), Neurod2 (Mm00440465_g1), Prkaca (Mm00660092_m1), Saa3 (Mm00441203_m1) and Srf (Mm00491032_m1). Pgk1 (Mm00435617_m1) was shown not to change by comparing threshold cycle (C T ) values for both vehicle and LPS treatment groups, and was therefore used as an endogenous control. Statistical analysis was performed by calculating the difference in threshold cycle (DC T ) between a given target gene and Pgk1, and then by comparing the DC T values between vehicle (n ¼ 7) and LPS (n ¼ 8) treatment groups with Student's t-test. The relative expression of target genes was computed using the DDC T method. 59 
